Skip to main content
. 2022 Sep 22;30:100599. doi: 10.1016/j.lanwpc.2022.100599

Table 1.

Clinical characteristics in people with normoglycaemia and prediabetes at baseline.

Normoglycaemia Prediabetes
Number 1,474,413 528,948
Age, years 55·0 (44·0, 65·0) 61·0 (52·0, 71·0)
Men, n (%) 603,274 (40·9) 271,198 (51·3)
Total cholesterol, mmol/L 5·1 (4·5, 5·8) 5·2 (4·5, 5·9)
LDL-C, mmol/L 3·0 (2·5, 3·6) 3·1 (2·5, 3·7)
Triglyceride/HDL-C 0·8 (0·5, 1·3) 1·0 (0·6, 1·6)
Haemoglobin, g/dL 13·5 (12·4, 14·5) 13·7 (12·6, 14·7)
Albumin, g/L 42·3 (40·0, 45·0) 42·0 (39·0, 44·6)
History of CVD, n (%)a 85,328 (5·8) 54,660 (10·3)
History of CKD, n (%)a 151,076 (10·2) 84,606 (16·0)
History of CHF, n (%)a 15,881 (1·1) 11,367 (2·1)
History of cancer, n (%)a 40,069 (2·7) 20,031 (3·8)
Use of blood pressure medications, n (%) 3,807 (0·3) 2,696 (0·5)
Use of lipid-regulating drugs, n (%) 113,582 (7·7) 73,769 (13·9)
a

History of a disease refers to a person met criteria for these morbidities from 1st January 2000 until baseline. CHF: Congestive heart failure; CKD: chronic kidney disease; CVD: cardiovascular disease; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.